Exclusive

Publication

Byline

Location

US Patent Issued to CHANGEN THERAPEUTICS (SHANGHAI) on Sept. 8 for "Immunotherapy method of targeted chemokine and cytokine delivery by mesenchymal stem cell" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,372, issued on Sept. 8, was assigned to CHANGEN THERAPEUTICS (SHANGHAI) Co. LTD. (Shanghai). "Immunotherapy method of targeted chemokine an... Read More


US Patent Issued to POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION on Sept. 8 for "Porcine stomach mucosal tissue decellularization method for culturing stomach or stomach cancer tissues, composition for producing scaffold, and method for culturing tissue" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,373, issued on Sept. 8, was assigned to POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION (Pohang-si, South Korea). "Porcine stomach muc... Read More


US Patent Issued to SAMYANG on Sept. 8 for "Glycosyltransferase and Steviol glucoside preparation method using same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,374, issued on Sept. 8, was assigned to SAMYANG Corp. (Seoul, South Korea). "Glycosyltransferase and Steviol glucoside preparation method u... Read More


US Patent Issued to NOVOZYMES on Sept. 8 for "Alpha-amylase variants" (Danish Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,375, issued on Sept. 8, was assigned to NOVOZYMES A/S (Bagsvaerd, Denmark). "Alpha-amylase variants" was invented by Carsten Andersen (Vaer... Read More


US Patent Issued to Codexis on Sept. 8 for "Engineered DNA ligase variants" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,376, issued on Sept. 8, was assigned to Codexis Inc. (Redwood City, Calif.). "Engineered DNA ligase variants" was invented by Jacob Hansen ... Read More


US Patent Issued to Arrowhead Pharmaceuticals on Sept. 8 for "RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use" (California, Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,377, issued on Sept. 8, was assigned to Arrowhead Pharmaceuticals Inc. (Pasadena, Calif.). "RNAi agents and compositions for inhibiting exp... Read More


US Patent Issued to The Johns Hopkins University on Sept. 8 for "Modulating SYNGAP" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,378, issued on Sept. 8, was assigned to The Johns Hopkins University (Baltimore). "Modulating SYNGAP" was invented by Richard Huganir (Balt... Read More


US Patent Issued to Wyvern Pharmaceuticals on Sept. 8 for "Composition for regulating production of interfering ribonucleic acid" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,379, issued on Sept. 8, was assigned to Wyvern Pharmaceuticals Inc. (Caglary, Canada). "Composition for regulating production of interferin... Read More


US Patent Issued to Wyvern Pharmaceuticals on Sept. 8 for "Composition for regulating production of interfering ribonucleic acid" (Canadian Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,380, issued on Sept. 8, was assigned to Wyvern Pharmaceuticals Inc. (Calgary, Canada). "Composition for regulating production of interferin... Read More


US Patent Issued to The Research Foundation for the State University of New York on Sept. 8 for "Methods and compositions for inactivating interleukin-2-inducible t-cell kinase (ITK)" (New York Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,381, issued on Sept. 8, was assigned to The Research Foundation for the State University of New York (Albany, N.Y.). "Methods and compositi... Read More